Pharmafile Logo
Pharmafocus logo
Advanced Search

infectious diseases

Showing 7 posts of 22 posts found.

gehrynovartis

Novartis cuts 20% of research projects

November 1, 2018
Business Services, Research and Development Business, Novartis, gene therapy, infectious diseases, research

Swiss multinational Novartis has cut a fifth of its research projects, as it abandons 90 of its 430 drug development …

News

J&J announce promising Phase 1/2a results for HIV vaccine

October 23, 2018
Manufacturing and Production AIDS, HIV, J&J, JJ, Vaccine, infectious diseases

The world may be one step closer to discovering a preventative vaccine for HIV following American multinational Johnson & Johnson’s …

News

US FDA approves HPV vaccine for men and women aged 27-45

October 8, 2018
Sales and Marketing CDC, Cancer, FDA, HPV, approval, infectious diseases, vaccines

The US Food and Drug Administration have approved the use of HPV vaccine Gardasil 9 for both men and woman …

News
bill_gates_-_world_economic_forum_annual_meeting_davos_2008_number2

Gates Foundation invest in Immunocore, warning of infectious disease threat

September 20, 2017
Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, infectious diseases, pharma, pharmaceutical

It has been announced that the Bill & Melina Gates Foundation will invest up to $40 million in UK-based Immunocore …

News
pharmacy Senegal

UK Government commits £1 billion to malaria fight

January 26, 2016
Manufacturing and Production Bill Gates, Chancellor, George Osborne, Ross Fund, infectious diseases, malaria

Chancellor George Osborne has set out details of a billion pound fund to develop, test and produce new products to …

News
Zerbaxa

Cubist boosts antibiotics market presence

December 22, 2014
Sales and Marketing Antibiotics, Zerbaxa, antimicrobial resistance, bacteria, cubist, infections, infectious diseases

Cubist has followed-up its successful European approval for a new antibiotic by winning an endorsement by the US FDA. The …

News

GSK moves into diagnostics with Enigma

August 12, 2011
Sales and Marketing Diagnostics, GSK, infectious diseases

GlaxoSmithKline has signed a deal to develop new tests with Enigma Diagnostics, extending a 2009 agreement with the Salisbury-based company. …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024